"Taking an idea isn’t theft. Taking an idea is an oxymoron. Ideas belong to all of us" - Seth Godin @ThisIsSethsBlog https://t.co/eY8Tj0c1rF

2022 Rheumatology Year in Review 2022 was a year of recovery, discovery, and some losses. While still dealing with the aftermath of COVID-19, rheumatologists were resilient as leaders for their patients and research in advancing rheumatologic care. https://t.co/L7bUUdHqQF https://t.co/aVSXyzF3yy

According to a 2022 Review of Physician and Advanced Practitioner Recruiting Incentives" by Merritt Hawkins, orthopedics has the highest salary & pediatrics the lowest. Rheumatology: Low: $200,000, Average: $258,000, High: $325,000 https://t.co/PmmAj9s2Vq https://t.co/nEzp4pWiG0

Reuters reports that in 2021, the median annual price was $180,000 for the 1st 30 drugs FDA approved. In 2022, the median annual cost was $222,003 for newly approved drugs. https://t.co/laxw6DacHr https://t.co/kRM7EbrD72

Do not take antacids or PPI with mycophenolate. Magnesium & aluminium hydroxide antacids (Maalox) will lower MMF Cmax 33% & AUC 17% if given simultaneously. PPI also lowers AUC by ~33% https://t.co/qXspeRj0eV https://t.co/g7L2OIgFKc https://t.co/egZFKLbNC7 https://t.co/6M3KIG1kTz

Hydroxychloroquine significantly lowers Alzheimer’s and dementia risk. Study of g 109,124 #RA pts starting HCQ or MTX. showed an 8-16% lower risk. https://t.co/gV4AYHRwmU https://t.co/crbTu1zr3E

Differential Dx of hyperferritinemia (≥500 μg/) in critically ill ICU pts includes: sepsis, liver disease/failure, hematological malignancy, HLH. Single center study of 2583 patients https://t.co/F5Dz2qpmAy https://t.co/ZWnxHGoQR1

ACP Recommends Bisphosphonates as Initial Therapy for Osteoporosis The guideline is based on a systemic review and network meta-analysis conducted by the ACP Center for Evidence Reviews at the Portland Veteran Affairs Research Foundation. https://t.co/Tx6PnpCEOp https://t.co/AVsnC1yubI

Weekly (Ozempic) semaglutide SC was given for obesity, 3-6 mos to 408 pts with BMI> 27. Wt loss was 5.9% (6.7 kg) @3 mos & 10.9% (12.3 kg) @6 mos. 55%) had >10% & 8% had > 20% wt loss. NIDDM pts had less wt loss vs non-DM pts. https://t.co/LXpP5OR5GA https://t.co/ioPA9WpJu3

520 RA pts were screened with FibroScan (liver fibrosis)- F3 or F4 liver fibrosis seen 13.3% of controls vs 12.7% arthritis pts. MTX was not significantly correlated w/ higher FS scores. Liver stiffness was correlated w/ BMI, waist, male , age. https://t.co/nINWp8vbUu